PMAIP1 and non-small cell lung carcinoma: More importantly, the conserved correlation between NOXA and p-p38 verified in the NSCLC tissues (Fig. 7I), coupled with survival data linking their co-expression to poor prognosis (Fig. 7J), identified the p-p38/NOXA axis as a clinically actionable biomarker.